(2023)
Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
BREAST.
72,
(2023)
Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
INTERNATIONAL JOURNAL OF SURGERY.
(2023)
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women with Hormone Receptor-Positive Breast Cancer after Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
JOURNAL OF CLINICAL ONCOLOGY.
41,
31
(2023)
Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma.
JAMA NETWORK OPEN.
6,
11
(2023)
The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer.
CANCERS.
15,
22
(2023)
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis.
CANCERS.
15,
22
(2023)
Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.
JOURNAL OF BREAST CANCER.
26,
6
(2023)
Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.
WORLD JOURNAL OF CLINICAL CASES.
11,
27
(2023)
Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring BRCA1/BRAC2 Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing.
CANCERS.
15,
18
(2023)
Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis.
JMIR PUBLIC HEALTH AND SURVEILLANCE.
9,
1
(2023)
Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study.
CANCERS.
15,
13
(2023)
Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
105,
1
(2023)
Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG).
BMC CANCER.
23,
1
(2023)
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
NATURE COMMUNICATIONS.
14,
1
(2023)
Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study.
JOURNAL OF BREAST CANCER.
26,
2
(2023)
Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level.
JOURNAL OF BREAST CANCER.
26,
2
(2023)
Robot-assisted mastectomy: next major advance in breast cancer surgery.
BRITISH JOURNAL OF SURGERY.
110,
4
(2023)
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis.
CANCERS.
15,
5